BIOMARIN PHARMACEUTICAL INC (BMRN)
Data as of , from SEC Form 4 filings.
Net insider selling (90d)Watch BMRN
See up to 3 months of BMRN. The 7-day demo opens the 1M and 3M ranges and puts BMRN on your watchlist.
Start 7-day demoLatest BMRN insider trades
George Eric Davis - OfficerOpen-market sale$1.16M
Gregory R. Friberg - OfficerOpen-market sale$177K
About BIOMARIN PHARMACEUTICAL INC (BMRN)
BIOMARIN PHARMACEUTICAL INC is an SEC registrant, filing under CIK 0001048477, classified as pharmaceutical preparations. It is grouped with Health Care companies on this site.
BMRN Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 1 | 17,557 | $1.16M |
| Grant or award | 1 | 6,140 | |
| Tax withholding / forfeiture | 1 | 4,086 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
BMRN insider transactions (Form 4)
5148 Form 4 filings on record, the earliest from Oct 1, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Gregory R. Friberg - Officer | Tax withholding / forfeiture | Common Stock | 4,086 | $60.00 | $245K | |
| Robert M. Plenge - Director | Grant or award | Common Stock | 6,140 | $0.00 footnote F1 | - | |
| ||||||
| George Eric Davis - Officer | Open-market sale | Common Stock | 17,557 | $66.28 footnote F1 | $1.16M | |
| ||||||
| Athena Countouriotis - Director | Grant or award | Common Stock | 7,490 | $0.00 footnote F1 | - | |
| ||||||
 Timothy P. Walbert - Director | Grant or award | Common Stock | 7,490 | $0.00 footnote F1 | - | |
| ||||||
 Maykin Ho - Director | Grant or award | Common Stock | 7,490 | $0.00 footnote F1 | - | |
| ||||||
 Robert J. Hombach - Director | Grant or award | Common Stock | 7,490 | $0.00 footnote F1 | - | |
| ||||||
| Mark J. Enyedy - Director | Grant or award | Common Stock | 7,490 | $0.00 footnote F1 | - | |
| ||||||
| Willard H. Dere - Director | Grant or award | Common Stock | 7,490 | $0.00 footnote F1 | - | |
| ||||||
| Ian T. Clark - Director | Grant or award | Common Stock | 7,490 | $0.00 footnote F1 | - | |
| ||||||
| Barbara W. Bodem - Director | Grant or award | Common Stock | 7,490 | $0.00 footnote F1 | - | |
| ||||||
| Elizabeth M. Anderson - Director | Grant or award | Common Stock | 7,490 | $0.00 footnote F1 | - | |
| ||||||
| Cristin Hubbard - Officer | Tax withholding / forfeiture | Common Stock | 2,318 | $50.20 | $116K | |
| Gregory R. Friberg - Officer | Open-market sale | Common Stock | 3,281 | $53.85 | $177K | |
| George Eric Davis - Officer | Tax withholding / forfeiture | Common Stock | 1,273 | $56.05 | $71K | |
| Charles Greg Guyer - Officer | Tax withholding / forfeiture | Common Stock | 1,693 | $56.05 | $95K | |
| Brian Mueller - Officer | Tax withholding / forfeiture | Common Stock | 2,117 | $56.05 | $119K | |
| Alexander Hardy - Officer | Tax withholding / forfeiture | Common Stock | 4,252 | $56.05 | $238K | |
| Cristin Hubbard - Officer | Tax withholding / forfeiture | Common Stock | 1,245 | $56.05 | $70K | |
| Cristin Hubbard - Officer | Grant or award | Common Stock | 15,410 | $0.00 footnote F1 | - | |
| Cristin Hubbard - Officer | Grant or award | Stock Option (Right to Buy Common Stock) | 36,680 | $0.00 | - | |
| ||||||
| Gregory R. Friberg - Officer | Tax withholding / forfeiture | Common Stock | 1,629 | $56.05 | $91K | |
| Gregory R. Friberg - Officer | Grant or award | Common Stock | 19,150 | $0.00 footnote F1 | - | |
| Gregory R. Friberg - Officer | Grant or award | Stock Option (Right to Buy Common Stock) | 45,600 | $0.00 | - | |
| ||||||
| Charles Greg Guyer - Officer | Tax withholding / forfeiture | Common Stock | 9,109 | $58.51 | $533K | |
| Charles Greg Guyer - Officer | Grant or award | Common Stock | 14,990 | $0.00 footnote F1 | - | |
| Charles Greg Guyer - Officer | Grant or award | Stock Option (Right to Buy Common Stock) | 35,680 | $0.00 | - | |
| ||||||
| George Eric Davis - Officer | Tax withholding / forfeiture | Common Stock | 7,177 | $58.51 | $420K | |
| George Eric Davis - Officer | Grant or award | Common Stock | 14,570 | $0.00 footnote F1 | - | |
| George Eric Davis - Officer | Grant or award | Stock Option (Right to Buy Common Stock) | 34,690 | $0.00 | - | |
| ||||||
| Brian Mueller - Officer | Tax withholding / forfeiture | Common Stock | 9,945 | $58.51 | $582K | |
| Brian Mueller - Officer | Grant or award | Common Stock | 18,740 | $0.00 footnote F1 | - | |
| Brian Mueller - Officer | Grant or award | Stock Option (Right to Buy Common Stock) | 44,600 | $0.00 | - | |
| ||||||
| Alexander Hardy - Officer | Tax withholding / forfeiture | Common Stock | 2,941 | $58.51 | $172K | |
| Alexander Hardy - Officer | Grant or award | Common Stock | 62,440 | $0.00 footnote F1 | - | |
| Alexander Hardy - Officer | Grant or award | Stock Option (Right to Buy Common Stock) | 89,200 | $0.00 | - | |
| ||||||
| Charles Greg Guyer - Officer | Open-market sale | Common Stock | 16,486 | $60.46 footnote F1 | $997K | |
| ||||||
| Charles Greg Guyer - Officer | Grant or award | Common Stock | 6,176 footnote F2,F3 | $0.00 | - | |
| Charles Greg Guyer - Officer | Grant or award | Common Stock | 6,675 footnote F3,F4 | $0.00 | - | |
| Charles Greg Guyer - Officer | Grant or award | Common Stock | 2,371 footnote F3,F5 | $0.00 | - | |
| ||||||
| Gregory R. Friberg - Officer | Open-market sale | Common Stock | 6,326 | $60.38 footnote F1 | $382K | |
| ||||||
| George Eric Davis - Officer | Open-market sale | Common Stock | 26,061 | $61.36 | $1.60M | |
| George Eric Davis - Officer | Grant or award | Common Stock | 6,177 footnote F2,F3 | $0.00 | - | |
| George Eric Davis - Officer | Grant or award | Common Stock | 6,675 footnote F3,F4 | $0.00 | - | |
| George Eric Davis - Officer | Grant or award | Common Stock | 2,372 footnote F3,F5 | $0.00 | - | |
| ||||||
| Brian Mueller - Officer | Grant or award | Common Stock | 6,683 footnote F2,F3 | $0.00 | - | |
| Brian Mueller - Officer | Grant or award | Common Stock | 7,230 footnote F3,F4 | $0.00 | - | |
| Brian Mueller - Officer | Grant or award | Common Stock | 2,569 footnote F3,F5 | $0.00 | - | |
| ||||||
 Rashmi Virendra Ramchandani - Officer | Grant or award | Common Stock | 18,540 | $0.00 footnote F1 | - | |
| Rashmi Virendra Ramchandani - Officer | Grant or award | Common Stock | 7,070 | $0.00 footnote F1 | - | |
| Rashmi Virendra Ramchandani - Officer | Grant or award | Stock Option (Right to Buy Common Stock) | 18,220 | $0.00 | - | |
| ||||||
Item 2.02
Item 1.01
Item 8.01
Item 5.02
Recent BMRN Form 144 notices of proposed sale
2An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Davis George Eric | Officer | 17,557 | $1.16M | View on EDGAR | |
| - | - | - | - |
BMRN insider trading FAQ
What is the latest insider trade for BMRN?
BIOMARIN PHARMACEUTICAL INC (BMRN) had 3 insider filings in the last 90 days, with the most recent on 2026-10-01. The full record for BMRN runs to 48 Form 4 filings, the earliest from 2024-10-01. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying BMRN stock?
No insider purchases of BMRN were filed in the last 90 days.
How many insiders are selling BMRN stock?
1 insider sale of BMRN was filed in the last 90 days, totaling $1.16M.
Where can I see BMRN SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects BMRN Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Gregory R. Friberg view on EDGAR
- - Robert M. Plenge view on EDGAR
- - George Eric Davis view on EDGAR
- - Athena Countouriotis view on EDGAR
- - Timothy P. Walbert view on EDGAR
- - Maykin Ho view on EDGAR
- - Robert J. Hombach view on EDGAR
- - Mark J. Enyedy view on EDGAR
- - Willard H. Dere view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where BMRN's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow BMRN with a 7-day demo
- BMRN on your watchlist
- Every BMRN Form 4 filing on record
- Up to 3 months of BMRN price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
